Genoway (PA:ALGEN) — Stock Price
Genoway (PA:ALGEN) is currently trading at €2.50 EUR, down 0.40% today. Over the past 52 weeks, shares have ranged between €2.10 and €3.18. This page tracks Genoway's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Genoway (ALGEN) market capitalisation.
Genoway (ALGEN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Genoway's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Genoway Income Statement — Revenue, Profit & Earnings by Year
Genoway's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €20.96 Million | €22.06 Million | €20.05 Million | €17.05 Million | €14.02 Million |
| Cost of Revenue | — | €12.81 Million | €1.24 Million | €18.36 Million | €17.77 Million |
| Gross Profit | — | €-1.89 Million | €18.80 Million | €-1.31 Million | €-3.75 Million |
| Research & Development | — | — | — | — | — |
| SG&A | — | €19.66 Million | €17.03 Million | €15.13 Million | €14.57 Million |
| Total Operating Expenses | €19.42 Million | €12.91 Million | €16.74 Million | €11.00 Million | €848.38K |
| Operating Income | €1.53 Million | €1.81 Million | €2.07 Million | €949.84K | €-4.59 Million |
| EBITDA | €1.53 Million | €3.89 Million | €6.35 Million | €536.79K | €-1.88 Million |
| EBIT | — | €1.30 Million | €2.06 Million | €-1.80 Million | €-3.80 Million |
| Interest Expense | €285.00K | €146.51K | €109.07K | €122.03K | €274.72K |
| Income Before Tax | — | €-1.96 Million | €1.55 Million | €758.94K | €-4.08 Million |
| Income Tax Expense | €321.00K | €-3.79 Million | €-20.00K | €-2.70 Million | €-3.75 Million |
| Net Income | €928.00K | €1.83 Million | €1.57 Million | €777.75K | €-322.60K |
Genoway Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Genoway's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €31.80 Million | €31.84 Million | €32.92 Million | €32.50 Million | €27.57 Million |
| Total Current Assets | €17.45 Million | €17.73 Million | €19.82 Million | €19.33 Million | €14.52 Million |
| Cash & Equivalents | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Short-term Investments | — | €523.40K | €-36.30K | €-36.30K | — |
| Net Receivables | €7.01 Million | €5.60 Million | €13.59 Million | €6.36 Million | €5.35 Million |
| Inventory | €1.09 Million | €982.75K | €1.19 Million | €1.03 Million | €1.20 Million |
| Property, Plant & Equipment | €5.56 Million | €5.88 Million | €6.67 Million | €7.17 Million | €7.87 Million |
| Goodwill | €196.95K | €196.95K | €196.95K | €196.95K | €196.95K |
| Total Liabilities | €13.23 Million | €14.46 Million | €16.76 Million | €17.94 Million | €18.57 Million |
| Total Current Liabilities | €8.60 Million | €8.39 Million | €6.99 Million | €6.45 Million | €7.94 Million |
| Long-term Debt | €4.14 Million | €5.52 Million | €9.04 Million | €8.99 Million | €10.01 Million |
| Net Debt | €622.98K | €2.97 Million | €4.17 Million | €5.22 Million | €8.05 Million |
| Total Stockholder Equity | €18.57 Million | €17.38 Million | €16.17 Million | €14.72 Million | €9.00 Million |
| Retained Earnings | €2.60 Million | €810.98K | €-756.59K | €-1.53 Million | €-1.21 Million |
Genoway Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Genoway generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | €5.38 Million | €3.06 Million | €2.36 Million | €-561.34K | €-164.33K |
| Capital Expenditures | €2.39 Million | €1.78 Million | €1.92 Million | €2.28 Million | €4.52 Million |
| Free Cash Flow | €2.99 Million | €1.28 Million | €438.60K | €-2.84 Million | €-4.68 Million |
| Investing Cash Flow | €-2.86 Million | €-2.00 Million | €-1.94 Million | €-2.26 Million | €-4.75 Million |
| Financing Cash Flow | €-1.83 Million | €-1.69 Million | €-1.14 Million | €5.71 Million | €6.54 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €2.97 Million | €4.29 Million | €2.74 Million | €1.92 Million | €1.30 Million |
| Change in Cash | €698.07K | €-621.78K | €-727.35K | €2.88 Million | €1.63 Million |
Genoway Earnings History — EPS Actual vs. Analyst Estimates
Track Genoway's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 24, 2025 | 0.00 | 0.00 | — |
| Apr 29, 2025 | 0.00 | 0.00 | — |
| Oct 17, 2022 | 0.02 | 0.00 | — |
| Jul 18, 2022 | 0.04 | 0.00 | — |
| Sep 27, 2021 | -0.08 | 0.00 | — |
| Jun 23, 2021 | 0.04 | 0.00 | — |
| Sep 17, 2020 | -0.17 | 0.00 | — |
| May 14, 2020 | -0.18 | 0.00 | — |